CHRISTOPHER WHITEHEAD: Open Payments
NPI 1255861589 · BRICK, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$826 in 67 payments from 9 companies in 2025. Trend: 2023 $786 · 2024 $604 · 2025 $826
Food & beverage: $826
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 21 | $198 |
| Otsuka America Pharmaceutical, Inc. | 12 | $169 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 9 | $155 |
| Lundbeck LLC | 15 | $138 |
| Alkermes, Inc. | 5 | $86 |
| Axsome Therapeutics, Inc. | 2 | $29 |
| Janssen Pharmaceuticals, Inc | 1 | $18 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $17 |
| Lilly USA, LLC | 1 | $17 |
Products named: REXULTI, VRAYLAR, CAPLYTA, ARISTADA, LYBALVI, Auvelity, SPRAVATO, TRINTELLIX.
Industry payments across NJ — which companies pay providers there.
